Join Our Upcoming Webinar – Changes on Allele Frequencies Net Database to Support NGS in Histocompatibility & Immunogenetics

Join us at our Omixon Webinar to discover the changes happening to the allele frequencies database and the impact of NGS on histocompatibility and immunogenetics. The disruptive power of Next Generation Sequencing is reshaping the nature of modern Immunogenetics with the ability to fully characterize the necessary HLA genes for every patient. Omixon Holotype HLA is...

 

Read more

Join Our Upcoming Webinar – Changes on Allele Frequencies Net Database to Support NGS in Histocompatibility & Immunogenetics

Join us at our Omixon Webinar to discover the changes happening to the allele frequencies database and the impact of NGS on histocompatibility and immunogenetics. The disruptive power of Next Generation Sequencing is reshaping the nature of modern Immunogenetics with the ability to fully characterize the necessary HLA genes for every patient. Omixon Holotype HLA is...

 

Read more

Omixon Announce French Tender Victory

Omixon today announce that their flagship Holotype HLA assay and software solution for HLA typing by Next Generation Sequencing (NGS) has been selected as the HLA typing solution of choice by the Etablissement Français du Sang (the French National Blood Service, EFS). Omixon won a two-year competitive tender worth €6.5m,...

 

Read more